True. Clear as day, —- Prior to this offer
Post# of 36536
(Total Views: 354)
Posted On: 05/19/2021 10:20:19 PM
True. Clear as day,
—-
Prior to this offering, there has been no public market for shares of our Class B Common Stock. We will apply to have our Class B Common Stock listed on the Nasdaq Capital Market under the symbol “NGIO,” which listing is a condition to this offering.
There is no established trading market for the Purchase Warrants and we do not expect an active trading market to develop. We do not intend to list the Purchase Warrants on any securities exchange or other trading market. Without an active trading market, the liquidity of the Purchase Warrants will be limited.
Upon completion of this offering, we will be a “controlled company” within the meaning of the listing rules of The Nasdaq Stock Market LLC.
—-
Prior to this offering, there has been no public market for shares of our Class B Common Stock. We will apply to have our Class B Common Stock listed on the Nasdaq Capital Market under the symbol “NGIO,” which listing is a condition to this offering.
There is no established trading market for the Purchase Warrants and we do not expect an active trading market to develop. We do not intend to list the Purchase Warrants on any securities exchange or other trading market. Without an active trading market, the liquidity of the Purchase Warrants will be limited.
Upon completion of this offering, we will be a “controlled company” within the meaning of the listing rules of The Nasdaq Stock Market LLC.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼